BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 7, Pages 1537
Publisher
MDPI AG
Online
2017-07-18
DOI
10.3390/ijms18071537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Doxorubicin targets multiple players: A new view of an old problem
- (2018) Donato Cappetta et al. PHARMACOLOGICAL RESEARCH
- Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma
- (2017) Michael Olvedy et al. JOURNAL OF CLINICAL INVESTIGATION
- Bromodomain Histone Readers and Cancer
- (2017) Abhinav K Jain et al. JOURNAL OF MOLECULAR BIOLOGY
- Atypical teratoid rhabdoid tumor in the first year of life: the Canadian ATRT registry experience and review of the literature
- (2017) Mary Fossey et al. JOURNAL OF NEURO-ONCOLOGY
- Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism
- (2016) D. Morel et al. ANNALS OF ONCOLOGY
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes
- (2016) Pascal D. Johann et al. CANCER CELL
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation
- (2016) Angelina Stojanova et al. CELL CYCLE
- Progress in the Development of non-BET Bromodomain Chemical Probes
- (2016) Natalie H. Theodoulou et al. ChemMedChem
- Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
- (2016) Laetitia J. Martin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
- (2016) Anja F Hohmann et al. Nature Chemical Biology
- Atypical teratoid/rhabdoid tumors—current concepts, advances in biology, and potential future therapies
- (2016) Michael C. Frühwald et al. NEURO-ONCOLOGY
- Initial testing (stage 1) of tazemetostat (EPZ-6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program
- (2016) Raushan T. Kurmasheva et al. PEDIATRIC BLOOD & CANCER
- Prognostic relevance of SAMSN1 expression in gastric cancer
- (2016) Mitsuro Kanda et al. Oncology Letters
- Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma
- (2015) Satoshi Sueoka et al. ANNALS OF SURGICAL ONCOLOGY
- Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition
- (2015) Natalie H. Theodoulou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature
- (2015) D. Schrey et al. JOURNAL OF NEURO-ONCOLOGY
- A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications
- (2015) E. Megan Flynn et al. STRUCTURE
- Loss of function of SWI/SNF chromatin remodeling genes leads to genome instability of human lung cancer
- (2014) HAI-TAO HUANG et al. ONCOLOGY REPORTS
- A rationale to target the SWI/SNF complex for cancer therapy
- (2014) Anja F. Hohmann et al. TRENDS IN GENETICS
- Rhabdoid tumors: integrating biological insights with clinical success
- (2014) Franck Bourdeaut et al. Cancer Genetics
- SAMSN1 Is a Tumor Suppressor Gene in Multiple Myeloma
- (2014) Jacqueline E. Noll et al. NEOPLASIA
- The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells
- (2013) Kornelius Kerl et al. BMC CANCER
- DUSP6 regulates drug sensitivity by modulating DNA damage response
- (2013) T V Bagnyukova et al. BRITISH JOURNAL OF CANCER
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- Activation of β-catenin/TCF targets following loss of the tumor suppressor SNF5
- (2013) E L Mora-Blanco et al. ONCOGENE
- Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience
- (2013) Wafik Zaky et al. PEDIATRIC BLOOD & CANCER
- Fibroblast Growth Factor Receptors as Novel Therapeutic Targets in SNF5-Deleted Malignant Rhabdoid Tumors
- (2013) Simon Wöhrle et al. PLoS One
- Histone deacetylases expression in atypical teratoid rhabdoid tumors
- (2012) Simone Treiger Sredni et al. CHILDS NERVOUS SYSTEM
- Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity
- (2012) Anbarasi Kothandapani et al. EXPERIMENTAL CELL RESEARCH
- Role of the Non-Receptor Tyrosine Kinase Fes in Cancer
- (2011) F. Condorelli et al. CURRENT MEDICINAL CHEMISTRY
- FES/FER kinase signaling in hematopoietic cells and leukemias
- (2011) Andrew et al. Frontiers in Bioscience-Landmark
- The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3
- (2011) S. Rahman et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncogenic Transformation
- (2010) Boris G. Wilson et al. CANCER CELL
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- SLy2 targets the nuclear SAP30/HDAC1 complex
- (2010) Simone Brandt et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
- (2010) Zainab Jagani et al. NATURE MEDICINE
- Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP)
- (2010) John M. Maris et al. PEDIATRIC BLOOD & CANCER
- Oncogenesis Caused by Loss of the SNF5 Tumor Suppressor Is Dependent on Activity of BRG1, the ATPase of the SWI/SNF Chromatin Remodeling Complex
- (2009) X. Wang et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More